Skip to content

Randomized controlled clinical trial for the efficacy and safety of Kaihoujian inhalation for acute laryngitis

Randomized controlled clinical trial for the efficacy and safety of Kaihoujian inhalation for acute laryngitis

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900026660
Enrollment
Unknown
Registered
2019-10-17
Start date
2019-10-17
Completion date
Unknown
Last updated
2019-10-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

acute laryngitis

Interventions

Sponsors

Wangjing Hospital, China Academy of Chinese Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: (1) Patients meets the standard of Western medicine acute laryngitis (light and moderate); (2) Patients meets the standard of Chinese medicine of wind-heat invading lung; (3) Aged 18 to 65 years; (4) Patients who first visit ENT clinicians within 48 hours; (5) Patients who signed the informed consent form.

Exclusion criteria

Exclusion criteria: (1) Those with a body temperature higher than 37 degree C; (2) Those with common cold, influenza, acute tonsillitis, pharyngeal diphtheria, and Wensang's angina; (3) Those with acute tracheal-bronchitis, pneumonia, rheumatic fever , acute glomerulonephritis, rheumatic heart disease and other diseases; (4) Patients with severe primary diseases such as cardiovascular and endocrine or hematopoietic system and those with mental illness; (5) Patients with abnormal liver and kidney function tests, diabetes (6) WBC >= 1.2×10^9/L; (7) Pregnancy (defined as positive for pregnancy test), lactating woman or birth plan within half a year; (8) Accepted Chinese medicines or antibiotics who has similar efficacy in test drugs within 48 hours before enrollment; (9) Those who are participating in other drug clinical trials or known to be allergic to therapeutic drugs; (10) Those who believe that they are not suitable for the test; (11) Patients with obvious laryngeal mucosal edema by electronic laryngoscope.

Design outcomes

Primary

MeasureTime frame
symptoms;

Secondary

MeasureTime frame
larynscope sign;

Countries

China

Contacts

Public ContactFeng Wei

Wangjing Hospital, China Academy of Chinese Medical Sciences

13611147987@163.com+86 13611147987

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 11, 2026